Toggle navigation
TWunroll
TWunroll
faq
Contact US
#ClinicalTrials
Thomas Christie Williams
Williams_T_C
with Scotland due to start vaccination next week with the Pfizer/BioNTech BNT162b2 coronavirus vaccine, what do we know about it? a threadhttps://www.bbc.co.uk/news/uk-scotland-54984390 first of all, what type of vaccine is
Read more
Anant Bhan
AnantBhan
This is a letter which has been sent out by the ICMR DG yesterday. Now that multiple folks have confirmed genuineness, let me raise some issues with this letter on
Read more
Joanne Allman
canutes_lesson
Appalled by @BBCNews cheerleading for the #Pfizervaccine and complete lack of any scrutiny or rigorous analysis. Presenters have given up any pretence at journalism and morphed into #vaccine sales executives.
Read more
Anupam Singh
anupampom
A dive into'Patanjali Clinical Study'According to registration on CTRI, Initial sample size was planned for 60 in each group (placebo and Coronil).Primary Endpoint was Virological "Cure" at 14 days.(PCR negative)for
Read more
Daniel Catenacci
DocCatenacci
#Tweetorial1️Only ~40-60% of GEA pts receive 2L Rx in the USA, & the treatment landscape is fragmented. https://pubmed.ncbi.nlm.nih.gov/25792290/ https://pubmed.ncbi.nlm.nih.gov/31056940/ @TumorBoardTues #TumorBoardTuesday
Read more
Ewan Birney
ewanbirney
Again, a briefing for journalists, this time on vaccine trials, types of vaccine, efficacy and safety. (Context: I am a two-steps expert away from vaccine development; I am a one-step
Read more
Nayan Arora
captainchloride
When was the last time you were paged about a serum Cl- level? Probably never. Despite being the most abundant anion in the body, Cl- is under appreciated
Read more
Nutty Skeleton
lmartods
I don't know why you are acting crazy - I said small doses and done in controlled manner and talked about how it's easier to treathttps://twitter.com/lmartods/status/1326922712523169792 I did not say
Read more
Eric Secemsky MD MSc
EricSecemskyMD
PACLITAXEL TWEETORIAL1/Brief tweetorial to provide context of the importance of today's NEJM paper showing no mortality difference at 1-4 years between patients with peripheral artery disease treated with paclitaxel-coated (PCD)
Read more
Francisco Marty, MD
FranciscoMarty_
It took a while to digest the details of over 600 pages, but here is my review and comparative analysis of the #ACTT2 trial that compared #baricitinib vs. #placebo among
Read more
Delgoffe Lab
DelgoffeLab
Excited to share our latest work on the metabolism of T cell exhaustion in @NatImmunol. We identify mitochondrial stress, induced via combinations of signals common in tumor microenvironments, as a
Read more
Antonio Regalado
antonioregalado
23andMe to go public via a merger.Reportedly valued at $3.5 billionTicker symbol: $ME https://twitter.com/joelwinston/status/1357356823980957703 investment thesis slide. do they even know how dystopian this sounds? Useful ranking of largest
Read more
VigilantEyes
WomanSci
Vaccine summary : Three main approaches to design vaccine. 1. Use a whole virus or bacterium. 2.Just the parts of the germ that triggers the immune system 3. Just the
Read more
Felix Biotechnology
felixbiotech
In the last few months we've had many exciting developments at Felix! Check out the thread below to learn more about #Phage #ClinicalTrials, to take a look at our research
Read more
Hilda Bastian, PhD
hildabast
New data for the Oxford/AstraZeneca vaccine, with extra month's worth of data, & combining 4 trials from phase 1 to 3, focusing on 1st dose: Indian phase 2/3 trial still
Read more
Chris Albertyn 🍊
_ChrisAlbertyn
Something in the @AlzResearchUK #chatathon stuck with me: people questioning the value of an #dementia #earlydiagnosis when there's currently no 'effective' treatment available. Here are some of the reasons @BetterResearch
Read more
‹
1
2
3
4
5
6
7
›
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree